Conference abstract · 17 Sep 2018
Conference abstractPublished 28 Sep 2018
Decrease Doxorubicin resistance in breast cancer cell line by Anti-FOXM1 aptamer
Mashhad university of medical science, Iran
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The transcription factor Forkhead box M1 (FOXM1) is a key regulator of cell proliferation and is over-expressed in many forms of primary cancers, leading to uncontrolled cell division and genomic instability. FOXM1 is the top-ranked survival-associated transcription factor in patients with triple-negative breast cancer. Previous studies showed, silencing FOXM1 expression led to breast cancer cells to become more sensitive to Doxorubicin (Dox). The aim of this study was an improvement of therapeutic efficacy of Doxorubicin by co-delivery of FOXM1 and AS1411 aptamers in the liposomal formulation. The synergist effect of encapsulated aptamers in liposomes and Doxorubicin was studied by MTT and Annexin PI test. Combination of FOXM1 aptamer and Doxorubicin significantly improved therapeutic efficacy of Doxorubicin and lessened the required amount of Doxorubicin. The results of the MTT assay exhibited that combination therapy significantly decreased cell viability in MDA-MB-231, MCF-7, and 4T1 cells compared to CHO cells, which significantly preserved their viability. The Annexin PI test also showed FOXM1 aptamer increases apoptosis effect of Doxorubicin. In vivo findings confirmed that synergistic combination of FOXM1 aptamer and Dox enhanced antitumor effectiveness and reduced toxicity toward nontarget cells, opening up new insights into cancer treatment.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 3 Oct 2016
Effect of crocin and doxorubicin/radiation on a breast cancer cell line MCF-7
Conference abstract · 2 May 2023
Withaerin a induces metabolic crisis in breast cancer cell lines via decreasing c-myc expression: Potential therapeutic implication
Conference abstract · 2022
Decreased cell proliferation with 2, 3- Dichloro-5, 8-Dimethoxy-1, 4-Naphthoquinone and 4-Hydroxy Tamoxifen in triple negative breast cancer cell lines
Research article · 2011
Breast Cancer Patients Resistant to Endocrine Therapy Show Decreased Number of Cytotoxic Supressor Cells and Enhanced Production of Neoangiogenetic and Immunosupressive Factors
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Alia Moosavian”
